UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature cell biology, ISSN 1465-7392, 10/2011, Volume 13, Issue 10, pp. 1202 - 1213
Life Sciences & Biomedicine | Science & Technology | Cell Biology | Neovascularization, Physiologic - drug effects | Human Umbilical Vein Endothelial Cells - metabolism | Receptors, Notch - metabolism | Humans | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Receptors, Notch - antagonists & inhibitors | Transfection | RNA Interference | Time Factors | Forkhead Transcription Factors - metabolism | Vascular Endothelial Growth Factor D - genetics | Phosphatidylinositol 3-Kinase - metabolism | Vascular Endothelial Growth Factor Receptor-3 - deficiency | Transduction, Genetic | Retinal Vessels - metabolism | Endothelial Cells - metabolism | Rhombencephalon - blood supply | Gene Expression Regulation | Vascular Endothelial Growth Factor Receptor-3 - metabolism | Forkhead Transcription Factors - genetics | Vascular Endothelial Growth Factor C - genetics | Mice, Knockout | Antibodies - pharmacology | Macrophages - metabolism | Vascular Endothelial Growth Factor D - metabolism | Animals | Signal Transduction - drug effects | Vascular Endothelial Growth Factor B - metabolism | Vascular Endothelial Growth Factor C - metabolism | Cell Line, Tumor | Neovascularization, Pathologic - genetics | Vascular Endothelial Growth Factor B - genetics | Mice | Neovascularization, Pathologic - metabolism | Protein Kinase Inhibitors - pharmacology | Vascular Endothelial Growth Factor Receptor-3 - genetics | Endothelial Cells - drug effects | Physiological aspects | Blood vessels | Cellular signal transduction | Growth factor receptors | Research | Vascular endothelial growth factor | Index Medicus | Medicin och hälsovetenskap
Journal Article
Circulation research, ISSN 0009-7330, 10/2007, Volume 101, Issue 9, pp. 948 - 956
Vascular disease | Growth factors | Nitric oxide | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Vertebrates: cardiovascular system | Endocrine pancreas. Apud cells (diseases) | Male | Vascular Endothelial Growth Factor A - metabolism | Diabetes Mellitus, Type 2 - metabolism | RNA, Messenger - metabolism | Neovascularization, Pathologic - etiology | Diabetic Angiopathies - physiopathology | Ischemia - complications | Gene Expression - physiology | Up-Regulation - physiology | Diabetic Angiopathies - complications | Neovascularization, Pathologic - physiopathology | Diabetes Mellitus, Type 2 - complications | Disease Models, Animal | Vascular Endothelial Growth Factor Receptor-1 - genetics | Diabetic Angiopathies - metabolism | Mice, Inbred C57BL | Solubility | Ischemia - metabolism | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Ischemia - physiopathology | Animals | Diabetes Mellitus, Type 2 - physiopathology | Hindlimb - blood supply | Signal Transduction - physiology | Mice | Neovascularization, Pathologic - metabolism | Nitric Oxide - metabolism | Regional Blood Flow - physiology | Index Medicus
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 07/2011, Volume 286, Issue 29, pp. 25947 - 25962
Transcription, Genetic - drug effects | Vascular Endothelial Growth Factor A - biosynthesis | Vascular Endothelial Growth Factor Receptor-1 - antagonists & inhibitors | Humans | Angiostatic Proteins - pharmacology | Peptide Fragments - pharmacology | Vascular Endothelial Growth Factor A - genetics | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Vascular Endothelial Growth Factor A - pharmacology | Heparan Sulfate Proteoglycans - chemistry | Protein Structure, Tertiary | Cell Line | Peptide Fragments - metabolism | Endothelial Cells - metabolism | Angiostatic Proteins - chemistry | Rats | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Down-Regulation - drug effects | Vascular Endothelial Growth Factor Receptor-1 - chemistry | Protein Transport | Peptide Fragments - chemistry | Vascular Endothelial Growth Factor Receptor-2 - chemistry | Animals | Protein Tyrosine Phosphatase, Non-Receptor Type 6 - metabolism | Heparan Sulfate Proteoglycans - metabolism | Integrin alpha2beta1 - antagonists & inhibitors | Protein Binding | Integrin alpha2beta1 - metabolism | Angiostatic Proteins - metabolism | Endothelial Cells - drug effects | Heparan Sulfate Proteoglycans - pharmacology | Index Medicus | Proteoglycan Structure | VEGFR2 | Basement Membrane | Perlecan | Heparan Sulfate | Glycobiology and Extracellular Matrices | Cell Surface Receptor | α2β1 Integrin | Protein-Protein Interactions | Endorepellin | Heparan Sulfate Proteoglycan
Journal Article
The FEBS journal, ISSN 1742-464X, 05/2013, Volume 280, Issue 10, pp. 2194 - 2206
scratch wound | aortic ring | blocking antibodies | synstatin | Human Umbilical Vein Endothelial Cells | Neovascularization, Physiologic - drug effects | Phosphorylation | Antibodies - metabolism | Cadherins - metabolism | Humans | Aorta - metabolism | Ternary Complex Factors - metabolism | Integrin alphaVbeta3 - metabolism | Antigens, CD - metabolism | Vascular Endothelial Growth Factor A - pharmacology | Receptor Cross-Talk | Syndecan-1 - metabolism | Endothelial Cells - metabolism | Aorta - drug effects | Cells, Cultured | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Cell Adhesion | Peptides - pharmacology | Protein Interaction Mapping | Collagen - metabolism | Animals | Receptors, Somatomedin - metabolism | Protein Binding | Cadherins - antagonists & inhibitors | Mice | Receptors, Somatomedin - antagonists & inhibitors | Cell Movement | Endothelial Cells - drug effects | Index Medicus
Journal Article
Clinical and experimental immunology, ISSN 0009-9104, 06/2013, Volume 172, Issue 3, pp. 500 - 506
VEGFR2 | anti‐angiogenesis | PD‐1 | immune checkpoint | anti‐tumour immunity | Anti-tumour immunity | Immune checkpoint | Anti-angiogenesis | PD-1 | Life Sciences & Biomedicine | Immunology | Science & Technology | Colonic Neoplasms - therapy | Colonic Neoplasms - blood supply | Adenocarcinoma - immunology | Humans | Neoplasms, Experimental - therapy | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Vascular Endothelial Growth Factor Receptor-2 - immunology | Adenocarcinoma - blood supply | Drug Synergism | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Angiogenesis Inhibitors - administration & dosage | Animals | Adenocarcinoma - therapy | Antibodies, Monoclonal - administration & dosage | Colonic Neoplasms - immunology | Neoplasms, Experimental - immunology | Cell Line, Tumor | Female | Neovascularization, Pathologic - prevention & control | Mice | Mice, Inbred BALB C | Programmed Cell Death 1 Receptor - immunology | Lymphocytes, Tumor-Infiltrating - immunology | Neoplasms, Experimental - blood supply | Monoclonal antibodies | Neovascularization | Endothelial growth factors | Tumors | Medical research | Vascular endothelial growth factor | Index Medicus | anti-tumour immunity | Original | anti-angiogenesis
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 04/2012, Volume 36, Issue 4, pp. 629 - 639
VEGFR2 | Kaposi sarcoma | endothelial cell | angiosarcoma | fetal tis-sue | malignant meso-thelioma | adult tissue | mesothelial cell | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Immunohistochemistry | Neoplasms - metabolism | Vascular Neoplasms - surgery | Mesothelioma - pathology | Neoplasms - surgery | Tissue Array Analysis | Humans | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Male | Gestational Age | Embryo, Mammalian - metabolism | Mesothelioma - metabolism | Mesothelioma - surgery | Endothelium, Vascular - metabolism | Biomarkers, Tumor - metabolism | Vascular Neoplasms - pathology | Endothelium, Vascular - pathology | Female | Vascular Neoplasms - metabolism | Neoplasms - pathology | Endothelium, Vascular - embryology | Index Medicus | malignant mesothelioma | fetal tissue
Journal Article
The FEBS journal, ISSN 1742-464X, 05/2013, Volume 280, Issue 10, pp. 2271 - 2284
VEGF receptor 2 | perlecan | endorepellin | angiogenesis | VEGFA | Phosphorylation | Allosteric Regulation | Humans | Transcriptional Activation | Actins - metabolism | Peptide Fragments - pharmacology | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | Vascular Endothelial Growth Factor Receptor-2 - genetics | Transfection | HEK293 Cells | Binding Sites | Protein Structure, Tertiary | Recombinant Proteins - metabolism | Actin Cytoskeleton | Promoter Regions, Genetic | Peptide Fragments - metabolism | Signal Transduction | Endothelial Cells - metabolism | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Recombinant Proteins - genetics | Collagen - metabolism | Tyrosine - metabolism | Angiogenesis Inhibitors - metabolism | Heparan Sulfate Proteoglycans - metabolism | Protein Binding | Integrin alpha2beta1 - metabolism | Neovascularization, Physiologic | Cell Movement | Heparan Sulfate Proteoglycans - pharmacology | Proteins | Laminin | Vascular endothelial growth factor | Integrins | Signal transduction | Angiogenesis | Cellular biology | Binding sites | Index Medicus
Journal Article
Human pathology, ISSN 0046-8177, 2016, Volume 61, pp. 78 - 89
Pathology | Treatment response | Prognosis | Platelet-derived growth factor | Papillary renal cell carcinoma | Vascular endothelial growth factor | Life Sciences & Biomedicine | Science & Technology | Immunohistochemistry | Multivariate Analysis | Proto-Oncogene Proteins c-sis - analysis | Carcinoma, Renal Cell - chemistry | Humans | Middle Aged | Male | Kidney Neoplasms - chemistry | Molecular Targeted Therapy | Nephrectomy | Time Factors | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Retrospective Studies | Chemotherapy, Adjuvant | Kidney Neoplasms - therapy | Receptor, Platelet-Derived Growth Factor beta - analysis | Vascular Endothelial Growth Factor Receptor-2 - analysis | Biomarkers, Tumor - analysis | Carcinoma, Renal Cell - pathology | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Vascular Endothelial Growth Factor A - analysis | Chi-Square Distribution | Kidney Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Disease-Free Survival | Biopsy | Carcinoma, Renal Cell - therapy | Kidney Neoplasms - pathology | Aged | Index Medicus
Journal Article